Viewing Protocol Section

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section

Study NCT06199453
Ignite Creation Date: 2024-05-06 @ 7:57 PM
Last Modification Date: 2024-10-26 @ 3:17 PM
Study NCT ID: NCT06199453
Protocol Section: NCT06199453
Start Identification Module Data
Expand Identification Module Data
Brief Title: The Evaluation of the Effectiveness Safety and Tolerability of Treatment Using a PSMA-Lu177 in Patients With ACC- an Open Non-commercial Clinical Trial
Official Title: The Evaluation of the Effectiveness Safety and Tolerability of Treatment Using a Specialized Prostate-specific Membrane Antigen PSMA Labeled With Lutetium177 in Patients With Recurrent andor Metastatic Adenoid Cystic Carcinoma Originating From the Salivary Glands - an Open Non-commercial Clinical Trial
Acronym: LuRM_ACC2023
Organization: Maria Sklodowska-Curie National Research Institute of Oncology
Organization Class: OTHER
Organization Study ID: LuRM_ACC2023
Secondary IDs
Secondary ID Type Domain Link
EU CT 2023-504699-73-00 OTHER EMA None
Start Status Module Data
Status Verified Date: 2023-11
Overall Status: NOT_YET_RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
Lead Sponsor Class: OTHER
Lead Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload